Atai Life Sciences N.V. (ATAI)

NASDAQ: ATAI · Real-Time Price · USD

2.480

+0.010 (0.40%)

At close: Jun 5, 2025, 4:00 PM

2.430

-0.050 (-2.02%)

After-hours: Jun 5, 2025, 7:52 PM EDT

Atai Life Sciences Employees

Atai Life Sciences had 54 employees as of December 31, 2024. The number of employees decreased by 29 or -34.94% compared to the previous year.

Employees

54

Change (1Y)

-29

Growth (1Y)

-34.94%

Revenue / Employee

$34,500

Profits / Employee

-$2,759,019

Market Cap

497.87M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	54	-29	-34.94%
Dec 31, 2023	83	-50	-37.59%
Dec 31, 2022	133	46	52.87%
Dec 31, 2021	87	52	148.57%
Dec 31, 2020	35	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000
AbbVie	55,000

Employee Rankings

ATAI News

3 days ago - atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies - GlobeNewsWire
7 days ago - atai Life Sciences to Participate in Upcoming Investor Conferences - GlobeNewsWire
16 days ago - atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech's Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression - GlobeNewsWire
22 days ago - atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates - GlobeNewsWire
23 days ago - atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder - GlobeNewsWire
3 months ago - atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression - GlobeNewsWire
3 months ago - Atai: Following The Path That Spravato Laid And Moving Beyond It - Seeking Alpha
3 months ago - atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire